Meibomian Gland Dysfunction in Type 2 Diabetic Patients.

Xiaolei LinBinbin XuYuxi ZhengTerry G CourseyYinying ZhaoJunhua LiYana FuXuewen ChenYun-E Zhao

Published in: Journal of ophthalmology (2017)

Meibomian gland dysfunction (MGD) in type 2 diabetic patients is more severe compared with nondiabetic patients. Overall, most of the diabetic patients manifest as having asymptomatic MGD.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
oxidative stress
chronic kidney disease
prognostic factors
peritoneal dialysis
early onset
patient reported outcomes
drug induced